Results 171 to 180 of about 136,721 (312)

Investigation on the acceptance of an Industry 4.0 maturity model and improvement possibilities

, 2022
Alexander Kieroth, Manuel Brunner, Nadine Bachmann, Herbert Jodlbauer, Wolfgang Kurz   +4 more
openalex   +1 more source

KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells

FEBS Open Bio, EarlyView.
KLK7, a tissue kallikrein‐related peptidase, is elevated in advanced colorectal cancer and associated with shorter survival. High KLK7 levels in ascites correlate with peritoneal metastasis. In mice, KLK7 overexpression increases metastasis. In vitro, KLK7 enhances cancer cell proliferation, migration, adhesion, and spheroid formation, driving ...
Yosr Z. Haffani, Tobias Dreyer, Meriem Naim, Rea Lo Dico, Natalia A. Ignatenko, Viktor Magdolen, Dalila Darmoul   +6 more
wiley   +1 more source

A maturity model for the scientific review of clinical trial designs and their informativeness. [PDF]

Trials
Dolley S, Norman T, McNair D, Hartman D.
europepmc   +1 more source

Towards a Maturity Model for Clinical Decision Support Operations. [PDF]

Appl Clin Inform, 2019
Orenstein EW, Muthu N, Weitkamp AO, Ferro DF, Zeidlhack MD, Slagle J, Shelov E, Tobias MC.   +7 more
europepmc   +1 more source

Adoption of emerging technologies established on Comprehensive capability maturity model framework: A new practical model

, 2016
SM Kempegowda, Zenon Chaczko
openalex   +1 more source

Software Acquisition Capability Maturity Model (SA-CMM) Version 1.02

, 1999
Jack Cooper, M. Fisher, S. W. Sherer
openalex   +2 more sources

Research on the Capability Maturity Model of Digital Library Knowledge Management [PDF]

, 2016
Yang Zhiyin, Ruibin Zhu, Lina Zhang
openalex   +1 more source

Domain associated with zinc fingers‐containing NF90‐NF45 complex inhibits m6A modification of primary microRNA by suppressing METTL3/14 activity

FEBS Open Bio, EarlyView.
NF90–NF45 functions as a negative regulator of methyltransferase‐like 3/14 (METTL3/14)‐mediated N6‐methyladenosine (m6A) modification on primary microRNAs (pri‐miRNAs). NF90–NF45 binds to anti‐oncogenic pri‐miRNAs and inhibits their m6A modification, thereby suppressing the biogenesis of anti‐oncogenic miRNAs.
Takuma Higuchi, Shunsuke Morioka, Keiko Morisawa, Kazutsugu Matsukawa, Shingo Ashida, Takeshi Suzuki, Shuji Sakamoto   +6 more
wiley   +1 more source

Methodology for achieving the Capability Maturity Model Integrated in smalland emerging groups

, 2013
Hugo Arboleda, Andrés Paz, Rubby Casallas   +2 more
openalex   +1 more source

Pioglitazone plus (−)‐epigallocatechin gallate: a novel approach to enhance osteogenic performance in aged bone marrow mesenchymal stem cells

FEBS Open Bio, EarlyView.
Aged human bmMSCs are seeded in the scaffold. Osteoblastic induction can slightly increase cell's bone‐forming activity to produce bone‐like tissues, shown as the sporadic xylenol orange‐stained spots (the lower left image). Notably, pioglitazone plus EGCG co‐treatment dramatically increases cell's bone‐forming activity and bone‐like tissue production (
Ching‐Yun Chen, Jia‐Ci Jhang, Chun‐Yi Peng, Quốc Cường Nguyễn, Feng‐Huei Lin, Hung‐Ming Wu, Shankung Lin   +6 more
wiley   +1 more source